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Introduction
The tumor syndrome von Hippel-Lindau (VHL) disease is 
caused by heterozygous germline inactivation of the VHL tumor 
suppressor gene, which resides on chromosome 3p25 (Kaelin, 
2003). The cardinal feature of this hereditary cancer syndrome 
is the development of multiple vascular tumors called heman-
gioblastomas in the central nervous system and retina combined 
with clear cell carcinoma of the kidney and pheochromocytoma. 
VHL disease is an autosomal-dominant disorder, and tumor 
  development in VHL disease is linked to somatic inactivation of 
the remaining wild-type VHL allele, leading to loss of the wild-
type VHL gene product, VHL protein (pVHL). In the kidney, 
this event not only precipitates the development of clear cell 
carcinoma but is also associated with the growth of   premalignant 
renal cysts (Lubensky et al., 1996; Mandriota et al., 2002). 
  Restoration of pVHL expression is suffi  cient to suppress kidney 
tumor formation by pVHL-defective renal carcinoma cells 
in vivo, suggesting that tumorigenesis is a direct effect of the 
loss of both VHL alleles (Iliopoulos et al., 1995; Schoenfeld 
et al., 1998). Despite recent advances in our understanding of 
pVHL function in tumor formation (Kaelin, 2003; Ratcliffe, 
2003), the pathogenesis of cystic kidney disease in VHL  patients 
remains unknown.
Recently, the molecular pathogenesis of other cystic 
  kidney diseases has been linked to the monocilia of kidney cells 
(Benzing and Walz, 2006). Cilia are highly conserved organ-
elles that project from the surfaces of many cells (Igarashi 
and Somlo, 2002). The essential structure of renal monocilia 
consists of nine peripheral microtubule doublets forming the 
axoneme and surrounded by a membrane lipid bilayer that is 
continuous with the plasma membrane. The ciliary axoneme 
emerges from the basal body, a microtubule-based structure that 
also functions as the spindle-organizing center in mitosis. Cilia 
are sensory organelles (Snell et al., 2004; Pan et al., 2005), and 
it has been demonstrated that renal monocilia are involved in 
mechanosensation (Nauli et al., 2003; Praetorius and Spring, 
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ilia are specialized organelles that play an 
  important role in several biological processes, 
including mechanosensation, photoperception, 
and osmosignaling. Mutations in proteins localized to 
cilia have been implicated in a growing number of human 
diseases. In this study, we demonstrate that the von 
Hippel-Lindau (VHL) protein (pVHL) is a ciliary protein 
that controls ciliogenesis in kidney cells. Knockdown of 
pVHL impeded the formation of cilia in mouse inner 
  medullary collecting duct 3 kidney cells, whereas the 
  expression of pVHL in VHL-negative renal cancer cells 
rescued the ciliogenesis defect. Using green ﬂ  uorescent 
protein–tagged end-binding protein 1 to label   microtubule 
plus ends, we found that pVHL does not affect the micro-
tubule growth rate but is needed to orient the growth 
of microtubules toward the cell periphery, a prerequisite 
for the formation of cilia. Furthermore, pVHL interacts 
with the Par3–Par6–atypical PKC complex, suggesting a 
mechanism for linking polarity pathways to microtubule 
capture and ciliogenesis.
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2003a,b). The assembly and maintenance of cilia are mediated 
by intrafl  agellar transport (IFT), a bidirectional microtubule-
based transport system.
In this study, we demonstrate that pVHL localizes to the 
monocilia of kidney cells and controls ciliogenesis. Further-
more, we show that pVHL is essential for the oriented growth 
of microtubules toward the cell periphery, a prerequisite for 
the formation of cilia. Moreover, pVHL interacts with the 
Par3–Par6–atypical PKC (aPKC) polarity complex, suggesting 
that pVHL may connect Par3–Par6–aPKC polarity proteins to 
microtubule capture and ciliogenesis. Our results uncover a 
novel role for pVHL that links the pathogenesis of premalignant 
renal cysts in VHL disease with the role of kidney cell mono-
cilia in cystogenesis.
Results and discussion
We examined the localization of pVHL in polarized kidney cells 
using different anti-pVHL antisera. Renal tubular epithelial cells 
(MDCK clone II) were grown on cell culture inserts for a mini-
mum of 5 d after confl  uence to allow complete  epithelial polariza-
tion. We observed specifi  c staining in the cytoplasm of the cells 
and some nuclear staining, as described previously (Hergovich 
et al., 2003; and unpublished data). In addition, strong pVHL 
staining in monocilia was detected by several pVHL antibodies 
(Fig. 1). Cilia were identifi  ed with an antiacetylated tubulin anti-
body, which is a marker of the ciliary axoneme (Fig. 1, a and b). 
pVHL staining was completely blocked by adding an excess of 
recombinant pVHL peptide, confi  rming the staining specifi  city 
(Fig. 1 b). The same pVHL localization was observed using 
anti-pVHL antibody and anti–rabbit AlexaFluor-conjugated 
antisera but omitting the antiacetylated tubulin antisera, exclud-
ing cross-reactivity or bleed-through of the fl  uorescent label. 
No immunofl  uorescence was detected when secondary antibod-
ies were used alone (unpublished data).
Double and triple labeling of native human respiratory 
  epithelial cells revealed that pVHL is also present in motile 
cilia of respiratory epithelial cells (Fig. S1, available at http://
www.jcb.org/cgi/content/full/jcb.200605092/DC1). pVHL was 
detected in the ciliary axoneme (costained with antibodies against 
acetylated tubulin) and basal bodies (costained with antibodies 
against γ-tubulin). Immunoelectron microscopy of respiratory 
epithelial cells revealed that pVHL staining was confi  ned to 
protein complexes associated with the ciliary microtubules (Fig. 
S1 c). These data suggested that pVHL may be important for the 
formation or maintenance of cilia and prompted us to examine 
the effect of VHL deletion on ciliogenesis.
To address a possible role for pVHL in the formation or 
maintenance of cilia, we examined ciliogenesis in pVHL-
 defi  cient and in wild-type kidney cells. The A498 renal cell 
  carcinoma (RCC) cell line contains a single VHL allele with a 
frameshift mutation at codon 142, leading to the expression of a 
defective C-terminally truncated pVHL (Gnarra et al., 1994). 
Lentiviral vectors containing V5-tagged human pVHL30 cDNA 
or an empty cassette (control) were used to transduce pVHL-
defi  cient A498 RCC cells. The reexpression of pVHL was con-
fi  rmed by immunoblotting with anti-V5 antibody (Fig. 2 a). 
VHL-defective and -positive cells were grown 10 d after confl  u-
ence to allow epithelial polarization and cilia formation. Under 
the chosen conditions, VHL-negative cells did not assemble 
cilia. Even after >14 d after confl  uence, control cells trans-
duced with empty lentivirus did not form cilia (visualized with 
antiacetylated tubulin antibodies; Fig. 2, b and c). In contrast, 
the lentivirally mediated reexpression of pVHL resulted in the 
formation of intact monocilia at the apical surface of the cells, 
suggesting that pVHL expression is essential for cilia forma-
tion. Ciliogenesis was quantifi  ed by blinded counting of cilia in 
two independent experiments (Fig. 2 b). Similar to wild-type 
cells, pVHL-reexpressing cells showed a ciliary localization of 
pVHL, as demonstrated by the costaining of pVHL with the 
cilia marker protein acetylated tubulin (Fig. 2 c). Reexpressed 
pVHL could also be stained with anti-V5 antibody, confi  rming 
specifi  c staining in monocilia (Fig. S2 a, available at http://
www.jcb.org/cgi/content/full/jcb.200605092/DC1).
Next, we engineered a cell line that expressed VHL under 
the control of a tetracyclin-dependent promoter. VHL-negative 
Figure 1.  pVHL is localized to renal monocilia. (a) Colocalization of 
pVHL and acetylated tubulin in primary cilia of MDCK cells. MDCK 
cells were grown on coverslips at 100% conﬂ  uence and cultured for 5 d 
before the experiment to allow full polarization and cilia formation. 
  Localization of pVHL was determined by immunoﬂ   uorescence using a 
pVHL-speciﬁ  c antibody (green, rabbit polyclonal; sc-5575) with confocal 
images captured at the level of the apical membrane. Cells were 
costained with mouse antiacetylated tubulin antibody (middle), a marker 
protein for cilia. All images were captured using sequential Cy3 and 
  AlexaFluor488 scans on a laser confocal microscope to eliminate bleed-
through signals from the green and red ﬂ  uorescence. (b) Speciﬁ  c local-
ization of pVHL in primary cilia was conﬁ  rmed by the use of an additional 
anti-VHL antibody (goat polyclonal; sc-1535) and blocking with recombi-
nant pVHL. Lower magniﬁ   cation (left) and higher magniﬁ  cation  views 
(middle) of ciliated cells are shown. Incubation of the speciﬁ  c pVHL anti-
body with a blocking recombinant protein (10-fold excess) resulted in the 
loss of pVHL staining in cilia, demonstrating speciﬁ  city of the antibody 
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A498 cells were lentivirally transduced to express a tet repres-
sor together with a tet-dependent VHL construct. Incubation of 
the cells in the presence of doxycycline resulted in pVHL 
expression already at very low doxycycline concentrations 
(Fig. 2 d). Several independent clones of cells were generated, 
plated at high density, and grown on cell culture inserts in the 
absence and presence of 500 ng/ml doxycycline for 5 d. As 
demonstrated in the previous paragraph, VHL-negative cells did 
not show cilia formation under the conditions chosen (unpub-
lished data). In contrast, doxycyclin-treated cells displayed the 
formation of monocilia ( 10% of cells). These monocilia again 
stained positive for pVHL (as demonstrated by stainings with 
an anti-V5 antibody; Fig. 2 d).
To further study a role for pVHL in the formation of cilia, 
we next searched for short hairpin RNAs (shRNAs) to inter-
fere with VHL expression in renal cells. To test the effi  cacy of 
candidate shRNAs, the cDNA of mouse VHL (coding sequence 
plus 3′ untranslated region [UTR]) was cloned into a bicistronic 
luciferase vector to fuse this cDNA with the coding sequence of 
Renilla reniformis luciferase. In this system, the activity of the 
R. reniformis luciferase is a quantitative parameter of RNA deg-
radation mediated by cotransfected shRNAs. Coexpressed fi  re-
fl  y (Photinus pyralis) luciferase served as a control to normalize 
for transfection effi  ciency, expression level, and cell number. 
Several shRNAs were synthesized based on publicly available 
prediction programs (Table I; Yuan et al., 2004). These reagents 
were then tested by sequentially measuring the activities of fi  refl  y 
and R. reniformis luciferases in a 96-well format (Fig. S3 a, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200605092/DC1). 
shRNA#3 resulted in an almost 70% knockdown of the re  porter 
construct (Fig. S3 a) and effi  cient knockdown of the mouse 
pVHL (Fig. S3 b). We used shRNA#3 cloned into a lentivirus 
Figure 2.  Lentivirally mediated reexpression of pVHL res-
cues the cilia-defective phenotype of VHL-negative renal epi-
thelial cells. (a) Lentiviral vectors containing human pVHL30 
cDNA or an empty cassette were generated and used to 
infect VHL-defective A498 RCC cells. Reexpression of pVHL 
was conﬁ  rmed by immunoblotting with VHL-speciﬁ  c antibody. 
#1 and #2 denote two different pools of transduced cells. 
(b) Ciliogenesis was quantiﬁ  ed by blinded counting of cilia 
in two independent experiments (three slides each). Error bars 
represent SD. (c) VHL-defective (left; lentiviral control) and 
-positive cells (right; lentiviral pVHL) were grown 10 d after 
conﬂ   uence to allow epithelial polarization and cilia forma-
tion. Red, acetylated tubulin; green, reexpressed V5-tagged 
pVHL; merge in the far right panels. (d) Doxycycline-induced 
reexpression of pVHL in tet-inducible A498 cells. Ttrp denotes the 
lentivirally mediated expression of Tet repressor. Top panel 
shows a dose-response curve (24 h of incubation). Doxycycline-
mediated pVHL expression is shown (bottom) and results in 
the formation of cilia in pVHL-expressing cells (right). Reex-
pressed pVHL was stained with an anti-V5 antibody.JCB • VOLUME 175 • NUMBER 4 • 2006  550
vector to selectively knockdown VHL expression in mouse 
inner medullary collecting duct 3 (mIMCD3) kidney cells. 
shRNA expression was monitored by simultaneous coexpres-
sion of GFP from the same construct (Fig. S3 c). This strategy 
allows the identifi  cation of cells that effectively express shRNA. 
Interestingly, this level of knockdown was not associated with 
a marked change in the growth rate of the cells. Cell growth 
and formation of a closed monolayer was indistinguishable in 
cells with and without VHL knockdown, suggesting that low 
levels of pVHL are suffi  cient to prevent tumorlike cell growth. 
The lentivirally mediated expression of shRNA#3 against VHL 
but not of a control scrambled shRNA inhibited cilia forma-
tion, supporting the concept that pVHL controls ciliogenesis. 
  Identical results were obtained with shRNA#2 (unpublished 
data). Importantly, although cilia formation was greatly attenu-
ated in VHL knockdown cells, ciliogenesis was not entirely ab-
rogated in this assay (some cilia could form at later stages).
Next, we examined the mechanism by which pVHL may 
affect ciliogenesis. The essential structure of cilia consists of 
nine peripheral microtubule doublets forming the axoneme 
and surrounded by a membrane lipid bilayer that is continuous 
with the plasma membrane (Rosenbaum and Witman, 2002). 
In microtubule sedimentation experiments, we found that pVHL 
associates with microtubules (Fig. 3 a), and immunoprecipita-
tion experiments revealed that pVHL interacts with β-tubulin 
(Fig. 3 b). Thus, it appears that pVHL is associated with mi-
crotubules. But how could this protein play a role in ciliogen-
esis? One possible explanation is that pVHL may have a direct 
effect on microtubule stability, as has been described previ-
ously by Hergovich et al. (2003). We tested this possibility by 
treating VHL-positive and -negative cells with 20 μM of the 
microtubule-depolarizing drug nocodazole for 20 min, staining 
the cells with antiacetylated tubulin antibody, and checking for 
the integrity of microtubules by fl  uorescence microscopy. We 
were particularly interested in an effect on the peripheral micro-
tubule network. However, we could not fi  nd an obvious defect 
in microtubule stability in VHL-negative cells or rescue from 
microtubule instability in pVHL-reexpressing cells (unpub-
lished data).
Alternatively, pVHL might infl  uence microtubule growth 
rates or their directionality and organization. To test this possi-
bility, we examined microtubule growth and directionality using 
end-binding protein 1 (EB1) tagged with GFP in VHL-positive 
and -negative cells by high speed time-lapse videos. EB1 and 
Figure 3.  pVHL associates with microtubules 
but does not affect microtubule growth or 
stability. (a) pVHL binds microtubules. Microtu-
bules were polymerized in vitro, and super-
natants and microtubule pellets were then 
subjected to SDS-PAGE and immunoblotted for 
the indicated proteins. (b) β-Tubulin coprecipi-
tates with pVHL. FLAG-tagged pVHL (F.VHL) or 
a control protein (F.GFP) were expressed in 
HEK 293T cells and precipitated with anti-
FLAG antibody. Western blot analysis was 
  performed with a β-tubulin–speciﬁ  c  antibody 
(top). Expression levels of β-tubulin in the ly-
sates are shown (bottom). (c) End-binding pro-
tein 1 (EB1) tagged with GFP tracks microtubule 
growth in the monocilia of kidney cells, sug-
gesting that this protein is a suitable reagent to 
study the microtubule formation required for 
ciliogenesis. GFP-EB1 was expressed in MDCK 
cells, and ﬂ  uorescence (1,024 × 1,024   pixels) 
as well as differential interference contrast 
(DIC) images were recorded with a confocal 
scanning microscope. The confocal pinhole was set to achieve an optical slice thickness of 0.9 μm (top). The bottom panel shows a z stack of the same 
area. (d) GFP-EB1 accumulates at the plus ends of microtubules. GFP-EB1 movements were visualized with high speed confocal microscopy. (e) VHL does 
not affect the number of growing microtubules at the cell cortex. To estimate the number of growing microtubules at the cell cortex, GFP-EB1–positive micro-
tubules were counted at the cell periphery in deﬁ  ned areas of interest and were compared in VHL-positive and -negative cells (n = 8). Tracking paths were 
measured in two square ﬁ  elds (256 μm
2) per cell positioned in the cytosol adjacent to the plasma membrane. Error bars represent SD. Bars, 5 μm.
Table I. Sequence information for hairpin constructs
Hairpin DNA sequence
a Target
mVHL #1 G  A  G  A  A  G  A  T  G  A  C  C  T  G  A  G  A  G  G  G  C  T  G  T  T  T  T  G  G  C  C  A  C  T  G  A  C  T  G  A  C  A  G  C  C  C  T  C  T  G  G  T  C  A  T  C  T  T  C  T cds
mVHL #2 G  T  T  A  A  C  C  A  G  A  A  G  T  C  C  A  T  C  A  T  G  G  G  T  T  T  T  G  G  C  C  A  C  T  G  A  C  T  G  A  C  C  C  A  T  G  A  T  G  C  T  T  C  T  G  G  T  T  A  A cds
mVHL #3 G  A  A  C  T  C  A  G  G  A  A  C  A  C  T  T  A  A  T  C  T  C  G  T  T  T  T  G  G  C  C  A  C  T  G  A  C  T  G  A  C  G  A  G  A  T  T  A  A  G  T  T  C  C  T  G  A  G  T  T 3′ UTR
mVHL #4 G  A  A  C  A  C  T  A  C  A  A  A  G  C  C  C  A  G  G  G  A  T  G  T  T  T  T  G  G  C  C  A  C  T  G  A  C  T  G  A  C  A  T  C  C  C  T  G  G  T  T  T  G  T  A  G  T  G  T  T 3′ UTR
mVHL #5 G  T  T  A  A  A  C  A  C  T  A  C  A  A  A  G  C  C  C  A  G  G  G  T  T  T  T  G  G  C  C  A  C  T  G  A  C  T  G  A  C  C  C  T  G  G  G  C  T  G  T  A  G  T  G  T  T  T  A  A 3′ UTR
hsaVHL #1 G  T  A  A  G  G  A  A  G  G  A  A  C  C  A  G  T  C  C  T  G  T  G  T  T  T  T  G  G  C  C  A  C  T  G  A  C  T  G  A  C  A  C  A  G  G  A  C  T  T  T  C  C  T  T  C  C  T  T  A 3′ UTR
Scrambled G  A  A  A  T  G  T  A  C  T  G  C  G  C  G  T  G  G  A  G  A  C  G  T  T  T  T  G  G  C  C  A  C  T  G  A  C  T  G  A  C  G  T  C  T  C  C  A  C  G  C  A  G  T  A  C  A  T  T  T None
cds, coding sequence.
aWithout overhangs; antisense target sequences (mature micro-RNA sequence) are indicated in bold.PVHL IS ESSENTIAL FOR CILIOGENESIS • SCHERMER ET AL. 551
its Caenorhabditis elegans homologue EBP-2 have been shown 
to decorate the plus ends of growing microtubules (Salaycik 
et al., 2005; Srayko et al., 2005) and, thus, can be used to dy-
namically monitor microtubule formation (Mimori-Kiyosue 
et al., 2000). GFP-EB1 decorates the microtubules of cilia (Fig. 
3 c), suggesting that this protein is a suitable reagent to study 
the microtubule formation required for ciliogenesis. Targeting 
to cilia is specifi  c to GFP-EB1 and could not be demonstrated 
with GFP alone (Fig. S2 b). However, because VHL-negative 
cells do not form cilia, studies addressing the microtubule 
formation required for ciliogenesis have to be performed in 
the cytoplasm.
We reasoned that monitoring microtubule formation at 
the cell cortex may allow us to address the mechanism that 
leads to the ciliogenesis defect in VHL-negative cells. In fact, 
this is what we found. Using life confocal microscopy, we 
observed multiple small dots of fl  uorescence moving at the 
cell periphery in both VHL-positive and -negative cells (Fig. 
3 d and Videos 1 and 2; available at http://www.jcb.org/cgi/
content/full/jcb.200605092/DC1). The number of forming micro-
tubules at the cell cortex did not differ in VHL-negative cells 
(Fig. 3 e). To study the direction and growth rate of microtu-
bules, fl  uorescent GFP-EB1 dot movements were tracked over 
10 s in high speed time-lapse videos using MetaMorph soft-
ware; microtubule growth rates and direction were determined 
from these data. Examples of microtubule growth tracks are 
shown in Fig. 4 a. To exclude the possibility that differentiation 
plays a major role in the effect of pVHL on microtubule growth, 
the experiments were performed in nonpolarized, nonconfl  uent 
cells (EB1-GFP–expressing A498 cells rescued with V5.lacZ or 
V5.VHL). The analyzed region of interest was chosen between 
the centrosome and the cell membrane. In undifferentiated 
cells, the centrosome is located near the nucleus, whereas in 
fully differentiated cells, the centrosome localizes to the apical 
membrane, where the cilium originates. Only undifferentiated 
cells with centrosomes close to the nucleus were taken for the 
analyses, excluding the possibility that polarization, reorienta-
tion of centrioles, changes in microtubular polarity, or marked 
differences in cell cycle progression are responsible for any of 
the effects observed.
As stated in the previous paragraph, we found no obvious 
difference in microtubule growth between VHL-positive and 
-negative cells. However, we noticed that in wild-type cells, the 
direction of growth of newly formed microtubules at the cell 
periphery is coordinated toward the outer plasma membrane, 
whereas in VHL-defi  cient cells, growth directions appear to be 
less coordinated (Fig. 4, a and b). To perform a statistical analy-
sis of the directionality of microtubule growth in regions of in-
terest in different cells, the microtubule growth directions were 
expressed as the deviation from a calculated sum vector of all 
growth directions in one particular experiment. The summary of 
fi  ve independent experiments revealed a statistically signifi  cant 
difference in deviation from the sum vectors in VHL-negative 
cells (Fig. 4 c), demonstrating that VHL defi  ciency affects the 
coordinated growth of microtubules. These data suggest that the 
defi  ciency in ciliogenesis in VHL-negative cells may be a result 
of the uncoordinated growth of microtubules.
Members of the family of Ras-related Rho GTPases have 
emerged as key regulators controlling microtubule–cortex inter-
actions and the coordinated growth of cortical microtubules 
(Gundersen et al., 2004; Jaffe and Hall, 2005). Three critical ef-
fectors of the GTPase-mediated microtubule control have been 
identifi  ed, including Par6 (Etienne-Manneville and Hall, 2003), 
IQGAP1 (Fukata et al., 2002; Watanabe et al., 2004), and the 
mammalian homologue of Diapharous (mDia1; Palazzo et al., 
2001). Interestingly, coimmunoprecipitation experiments re-
vealed a specifi  c interaction of pVHL with Par6 (Fig. 5 a). 
pVHL precipitated the Par3–Par6–PKCζ protein complex in 
human embryonic kidney (HEK) 293T cells (Fig. 5 b). Immuno-
precipitation of endogenous pVHL from the mouse kidney 
demonstrated that pVHL is in a complex with Par3, Par6, and 
Figure 4. VHL  deﬁ  ciency affects the directed growth of microtubules. 
(a) Representative trackings of EB1 tagged with GFP (GFP-EB1) in the 
cytoplasm of VHL-positive and -negative cells. Each trace represents the 
history of GFP-EB1 movement (microtubule growth) over sequential time 
frames with an acquisition rate of two images per second. (b) Microtubule 
growth events were expressed as the deviation from the mean angle 
  (depicted as the sum vector in bold) in VHL-positive and -negative cells. 
A representative experiment of five independent analyses is shown. 
(c) Tracking paths were measured in one to two square ﬁ  elds (256 μm
2) 
positioned in the cytosol in a total of 10 independent experiments (VHL 
negative and positive). As a measure for directed or nondirected move-
ment, the deviation of the individual growth angles from the mean angle 
was calculated in each square. Statistical analysis was performed for 
VHL-positive and -negative cells using the two-tailed t test (**, P < 0.01). 
Error bars represent the SEM.JCB • VOLUME 175 • NUMBER 4 • 2006  552
aPKC in vivo (Fig. 5 c). Moreover, aPKC (PKCζ) colocalized 
with pVHL in the monocilia of MDCK cells (Fig. 5 d). Collec-
tively, these data suggest that Par3– Par6–aPKC and pVHL may 
operate in the same pathway to regulate the cortical growth of 
microtubules and the formation of cilia.
Recently, the Par3–Par6–aPKC polarity proteins have 
been shown to localize to cilia and interact with the anterograde 
IFT motor kinesin-2, linking polarity proteins with IFT, micro-
tubules, and the formation of cilia (Fan et al., 2004). However, 
the exact mechanisms of how ciliogenesis, IFT, and polarity 
proteins may be intertwined remained elusive. We now show 
that pVHL also localizes to cilia, interacts with Par3–Par6–
aPKC, and controls ciliogenesis. Although we failed to detect 
kinesin-2 components in the complex (unpublished data), our 
data demonstrating a critical role for pVHL in controlling the 
growth direction of microtubules suggest a common function of 
pVHL, polarity proteins, and IFT in controlling microtubular 
orientation and dynamics. This adds another aspect to an impor-
tant role for pVHL in regulating the microtubule cytoskeleton in 
cells. Previous studies showed that pVHL stabilizes microtu-
bules (Hergovich et al., 2003) and infl  uences microtubule dy-
namics at the periphery of living cells (Lolkema et al., 2004). 
We now demonstrate that pVHL is critically involved in regulat-
ing the orientation of microtubular growth at the cell periphery. 
Because pVHL also interacts with Par6, which is a key regula-
tor of microtubule–cortex interactions and the coordinated 
growth of cortical microtubules (Etienne-Manneville and Hall, 
2003), it is conceivable that pVHL and Par6 are in a common 
pathway to regulate microtubule orientation. Well-regulated 
microtubule orientation is a prerequisite for ciliogenesis, so 
the function of pVHL in controlling cilia formation may be the 
result of a common function of pVHL, polarity proteins, and 
IFT in controlling microtubule dynamics in the cell. Future 
studies will have to address the question of how pVHL, polarity 
proteins, and IFT regulate microtubule dynamics independently 
of ciliogenesis.
These data assign a novel role for the tumor suppressor 
pVHL and have important implications for the understanding of 
VHL disease. A critical role of pVHL in regulating ciliogenesis 
has also been documented by others (Esteban et al., 2006; Lutz 
and Burk, 2006) and could explain why VHL patients can de-
velop polycystic kidney disease. Although much has been learned 
about the function of pVHL in tumorigenesis at the molecular 
level, the pathogenesis of premalignant kidney cysts in VHL pa-
tients has remained elusive (Kaelin, 2004). Thus, our fi  nding that 
pVHL plays a critical role in ciliogenesis sheds new light on the 
pathogenesis of premalignant kidney cysts in VHL patients.
Materials and methods
Plasmids and antibodies
HA- and FLAG-tagged human VHL constructs were provided by S.A. 
Karumanchi (Harvard Medical School, Boston, MA). Human VHL was 
cloned into pLenti6.V5/Dest and pLenti4/TO/V5/Dest (Invitrogen) using 
GATEWAY cloning technology. Mouse VHL (coding sequence and 3′ UTR) 
was PCR cloned from the full-length clone IRAV-6402536 (Open Biosys-
tems) into a modiﬁ  ed GATEWAY pENTR1A vector, and recombination was 
performed into pcDNA3.1.nV5.Dest to obtain V5.mVHL. GATEWAY vec-
tors and lentiviral constructs were obtained from Invitrogen or were provided 
by T. Tuschl and M. Landthaler (Rockefeller University, New York, NY), D. 
Trono (University of Geneva, Geneva, Switzerland), and L. Naldini (Uni-
versity of Torino, Torino, Italy). EB1-GFP was provided by Y. Mimori-Kiyosue 
(KAN Research Institute, Kyoto, Japan; Mimori-Kiyosue et al., 2000). Site-
directed mutagenesis was performed using the QuikChange Site-Directed 
Mutagenesis Kit (Stratagene). All plasmids were veriﬁ   ed by automated 
DNA sequencing. Antibodies were obtained from Sigma-Aldrich (anti-
FLAG, antiacetylated tubulin, and anti-PKCζ), Santa Cruz Biotechnology, 
Inc. (anti-myc, anti-HA, anti-VHL pAb, and anti-Par6), Oncogene Research 
Products (anti-VHL mAb), Serotec (anti-V5 mAb), Covance (anti-HA pAb), 
and Roche Biochemicals (anti-HA mAb).
Cell culture and transfections
HEK 293T cells were cultured in DME supplemented with 10% FBS. For 
transfection experiments, cells were grown until 60–80% conﬂ  uence and 
Figure 5.  pVHL interacts with the Par3–Par6–aPKC polarity 
complex. (a) VHL coprecipitates with Par6. FLAG-tagged Par6 
(F.Par6) or a control protein (F.GFP) were coexpressed with 
HA-tagged VHL (HA.VHL) in HEK 293T cells and precipitated 
with anti-FLAG antibody. Western blot analysis was per-
formed with anti-HA antibody (top). Expression levels of 
HA.VHL in the lysates are shown (bottom). (b) pVHL precipi-
tates the Par3–Par6–aPKC protein complex. V5-tagged Par6 
(V5.Par6), Par3 (150-kD isoform; V5.Par3), and aPKC 
(V5.PKCζ) were coexpressed with FLAG-tagged VHL or a con-
trol protein (F.EPS) in HEK 293T cells. pVHL and the control 
protein were precipitated with anti-FLAG antibody, and co-
precipitating Par3, Par6, and PKCζ were visualized with anti-
V5 antibody on Western blots (right). Expression levels of all 
proteins in the lysates are shown (left and bottom). (c) Native 
pVHL from mouse kidney lysates coprecipitates the Par3–
Par6–aPKC protein complex. Freshly isolated mouse kidneys 
were perfused with ice-cold PBS, lysed, and subjected to 
  immunoprecipitation with control or anti-pVHL antibodies. Pre-
cipitated pVHL and coprecipitating proteins were detected 
with speciﬁ  c antibodies. (d) Colocalization of pVHL and aPKC 
(PKCζ) in primary cilia of MDCK cells. MDCK cells were 
grown on Transwell ﬁ  lters  (0.4-μm pore size; polyesther; 
Corning) at 100% conﬂ  uence and cultured for 5 d before the 
experiment to allow full polarization and cilia formation.PVHL IS ESSENTIAL FOR CILIOGENESIS • SCHERMER ET AL. 553
transfected with plasmid DNA using a modiﬁ  ed calcium phosphate method 
as described previously (Benzing et al., 1999).
Coimmunoprecipitation
Coimmunoprecipitations were performed as described previously (Huber 
et al., 2001). In brief, HEK 293T cells were transiently transfected and 
lysed in a 1% Triton X-100 lysis buffer (1% Triton X-100, 20 mM Tris-HCl, 
pH 7.5, 50 mM NaCl, 50 mM NaF, 15 mM Na4P2O7, 2 mM Na3VO4, 
and protease inhibitors) for 15 min on ice. After centrifugation at 15,000 g 
for 15 min and ultracentrifugation at 100,000 g for 30 min (both at 4°C), 
cell lysates containing equal amounts of total protein were precleared with 
protein G–Sepharose and incubated for 1 h at 4°C with the appropriate 
antibody followed by incubation with 40 μl protein G–Sepharose beads 
for  3 h. The beads were washed extensively with lysis buffer, and bound 
proteins were resolved by 10% SDS-PAGE. For precipitation of endoge-
nous proteins, mouse kidneys were perfused in situ with ice-cold PBS and 
homogenized in 1 ml of lysis buffer (20 mM Tris-HCl, pH 7.5, 1% Triton 
X-100, 25 mM NaF, 12.5 mM Na4P2O7, 0.1 mM EDTA, 50 mM NaCl, 
2 mM Na3VO4, and protease inhibitors). After centrifugation to remove 
cellular debris, the supernatant was subjected to an ultracentrifugation 
at 100,000 g for 30 min followed by extensive preclearing with protein 
G–Sepharose. Immunoprecipitation was performed as described previ-
ously (Benzing et al., 2001). Coprecipitating proteins were detected after 
12% SDS-PAGE of the precipitates and immunoblotting.
Immunoﬂ  uorescence staining of MDCK, mIMCD3, and human respiratory 
epithelial cells
MDCK (strain II) or mIMCD3 cells were seeded on coverslips at 100% con-
ﬂ  uence and cultured for 5–7 d before the experiment. After washing with 
ice-cold PBS, cells were ﬁ  xed using 4% PFA, pH 7.5, and 0.05% Triton 
X-100 for 15 min at room temperature. Cells were washed three times with 
PBS, and double immunoﬂ  uorescence staining was performed sequentially 
with the antibodies as indicated. After washing, slides were incubated with 
the secondary antibody, Cy2- or AlexaFluor488-labeled anti–rabbit, and 
Cy3-labeled anti–mouse IgG, washed again, mounted in a commercially 
available antifade kit (DakoCytomation), and subjected to immunoﬂ  uores-
cence microscopy with a microscope (Axiovert200) equipped with the ap-
otome system and a CCD camera (Jena; all were obtained from Carl Zeiss 
MicroImaging, Inc.) or to confocal microscopy. Confocal images were 
taken using a laser-scanning microscope (LSM5) equipped with a 100× oil 
immersion objective (both were obtained from Carl Zeiss MicroImaging, 
Inc.). The appropriate controls were performed without the ﬁ  rst  and/or 
second primary antibodies. In some experiments, the primary antibody 
was mixed with a 10-fold excess of blocking peptide to proof speciﬁ  c stain-
ing. Human respiratory epithelial cells were obtained by transnasal brush 
biopsy using a cell collector (Cytobrush Plus; Medscand Malmö) and were 
suspended in RPMI 1640 without supplements. Samples were spread onto 
glass slides. Cells were ﬁ  xed with 4% PFA in PBS for 15 min and were per-
meabilized with 0.2% Triton X-100 in PBS for 5 min before blocking with 
0.5% skim milk in PBS overnight. Cells were incubated with primary anti-
bodies and secondary antibodies as described in Results.
To detect GFP-EB1 in cilia, ﬂ  uorescence images (1,024 × 1,024 
pixels) were recorded with a confocal scanning microscope (LSM NLO; 
Carl Zeiss MicroImaging, Inc.) equipped with a C-Apo 100× NA 1.3 oil 
immersion objective (Carl Zeiss MicroImaging, Inc.). The scanning speed 
was set to 0.12 s per image, corresponding to a pixel time of 1.60 μs. The 
usual pixel size was 0.06 μm in x/y, and the confocal pinhole was set 
to achieve an optical slice thickness of 0.9 μm. GFP-EB1 was excited at 
514 nm, and ﬂ  uorescence emission was collected above 516 nm.
Immunoelectron microscopy
Freshly isolated mouse trachea was cut into small pieces and immediately 
transferred to 2.5% PFA in PBS, pH 7.2, for 30 min, washed three times for 
10 min in 50 mM ammonium chloride in PBS, and permeabilized with 
0.15% Triton X-100 in PBS for 5 min. Incubation with rabbit anti-VHL pAbs 
for 4 h was followed by washing in PBS four times for 10 min and over-
night incubation with the secondary antibodies coupled to 5-nm gold parti-
cles (diluted 1:3 in PBS; GE Healthcare). Unbound antibodies were 
removed by several washings with PBS, and the cells were ﬁ  xed with glu-
taraldehyde (2.5%; 50 mM cacodylate buffer, pH 7.2) for 30 min at 4°C. 
Thereafter, cells were postﬁ  xed with 2% OsO4 for 60 min at 4°C, rinsed 
with water, dehydrated with ascending alcohol concentrations and propyl-
ene oxide, and processed for embedding in Epon. Ultrathin sections were 
cut with a microtome (Reichert-Jung) and examined with an electron micro-
scope (EM 10A; Carl Zeiss MicroImaging, Inc.).
RNA interference experiments
shRNAs were designed based on the prediction of publicly available 
  prediction programs (Yuan et al., 2004), which are summarized in Table I. 
shRNAs were cloned into the transient micro-RNA expression vector 
pcDNA6.2-GW/emGFP/miR (Invitrogen), which coexpresses the shRNA 
surrounded by miR-155–ﬂ  anking sequences together with emGFP. To moni-
tor the efﬁ  ciency of shRNA-mediated knockdown, we created a luciferase 
reporter construct using psicheck2 (Promega) in which the coding sequence 
and the 3′ UTR of VHL were fused to the coding sequence of R. reniformis 
luciferase as an artiﬁ  cial 3′ UTR. In addition to R. reniformis luciferase, this 
construct expresses ﬁ  reﬂ   y luciferase for internal control. 50 ng of the 
  reporter plasmid was cotransfected with 50 ng of the respective pcDNA6.2-
GW/emGFP/miR shRNA construct into HEK 293T cells in a 96-well format 
using LipofectAMINE 2000 (Invitrogen) as a transfection reagent. R. reniformis 
luciferase and ﬁ  reﬂ  y luciferase activities were measured by a dual-luciferase 
reporter assay system (Promega) in a luminometer (Mithras LB940; 
Berthold) 24 h after transfection. Transfections and measurements were 
performed in triplicate. Selected hairpins were GATEWAY cloned into 
pLenti4/V5/TO/Dest for stable lentiviral expression in mIMCD3 cells.
Confocal laser-scanning microscopy
For fast live cell imaging, cells were seeded on custom-built 35-mm glass-
bottom dishes and analyzed the next morning at subconﬂ  uent stages. Fluo-
rescence images (512 × 512 pixels) were recorded with a confocal slit 
scanning microscope (LSM5 LIVE; software 4.0; Carl Zeiss MicroImaging, 
Inc.) with a C-Apo 63× NA 1.4 oil immersion objective (Carl Zeiss Micro-
Imaging, Inc.) on a heating stage at 37°C in nonperfused condition for 30 s. 
The scanning speed was set to 0.12 s per image, corresponding to a pixel 
time of 232 μs; a delay of 500 ms was used between each image. 
The usual pixel size was 0.2 μm in x/y, and the confocal pinhole was set 
to achieve an optical slice thickness of 0.9 μm. EB1-GFP was excited at 
488 nm, and ﬂ   uorescence emission was collected above 505 nm. For 
quantiﬁ  cation of the growth direction of microtubules, tracking paths were 
analyzed for 10 s using MetaMorph software (Universal Imaging Corp.). 
Tracking paths were measured in one to two square ﬁ  elds (256 μm
2) posi-
tioned in the cytosol in a total of 10 independent experiments (VHL nega-
tive and positive). As a measure for directed or nondirected movement, the 
deviation of the individual growth angles from the mean angle was calcu-
lated in each square. For better visualization of EB1-GFP dots in the videos, 
γ adjustment was performed. Statistical analysis was performed for VHL-
positive and -negative cells using the two-tailed t test.
Online supplemental material
Videos 1 and 2 show representative time-lapse tracings of EB1-GFP 
ﬂ   uorescence in VHL-positive (Video 1) and -negative (Video 2) A498 
RCC cells. For the mode of data acquisition, refer to the previous 
  section. Fig. S1 shows that pVHL localizes to cilia in respiratory epithelial 
cells. Fig. S2 shows that cytosolic GFP does not enter the ciliary com-
partment. Fig. S3 shows that the knockdown of pVHL inhibits the 
formation of monocilia. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200605092/DC1.
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